Tech Company Financing Transactions

Diligent Pharma Funding Round

Diligent Pharma closed a $8.3 million Series A funding round on 5/15/2023. Investors included FCA Venture Partners, GenHenn Venture and PJC.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
The company intends to use the funds to scale its data and content strategy.

Company Information

Company Status
Private & Independent
Mailing Address
179 Nassau St 3A
Princeton, NJ 08542
Email Address
At Diligent we connect clinical research sponsors, CROs, technology and service providers - quickly, efficiently and at very low risk. This can reduce the time taken to start clinical trials by up to 70 days. The cloud-based Diligent Qualification Platform holds comprehensive Request For Information (RFI) details for industry suppliers around the world, as well as Vendor Qualification Assessments (VQAs) audited against latest industry standards.
Diligent Pharma LinkedIn Company Profile
Social Media
Diligent Pharma Company Twitter Account
Company News
Diligent Pharma News
Diligent Pharma on Facebook
Diligent Pharma on YouTube

Management Team

Email & Social
Chief Executive Officer
Patricia Leuchten
  Patricia Leuchten LinkedIn Profile  Patricia Leuchten Twitter Account  Patricia Leuchten News  Patricia Leuchten on Facebook
Chief Technical Officer
LeRoy Jones
  LeRoy Jones LinkedIn Profile  LeRoy Jones Twitter Account  LeRoy Jones News  LeRoy Jones on Facebook



Browse more venture capital transactions:

Prev: 5/15/2023: Worldcoin venture capital transaction
Next: 5/15/2023: Figorr (Formerly Gricd) venture capital transaction


Share this article


About Our VC Transactions Data

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary